596 results on '"Gaig, Carles"'
Search Results
2. CSF markers of neurodegeneration Alzheimer’s and Lewy body pathology in isolated REM sleep behavior disorder
3. Upper airway manifestations of anti-IgLON5 disease: Otorhinolaryngological point of view
4. Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease
5. New knowledge on anti-IgLON5 disease
6. Former participation in professional football as an occupation in patients with isolated REM sleep behavior disorder leading to a synucleinopathy: a case–control study
7. Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder
8. Case 4. 'Despite of CPAP Therapy, My Husband Still Has a Disturbed Nocturnal Sleep'
9. Case 38. A Sleepy Patient with 'Epileptic Seizures' and Disturbed Night Sleep
10. Peripheral α-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder
11. Scoring sleep in neurodegenerative diseases: A pilot study in the synucleinopathies
12. Motor symptoms in nonparaneoplastic CNS disorders associated with neural antibodies
13. Temporal distribution of sleep onset REM periods and N3 sleep in the MSLT and night polysomnogram of narcolepsy type 1 and other hypersomnias
14. Sleep architecture and sleep-disordered breathing in fatal insomnia
15. C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy
16. Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder
17. Documento internacional de consenso sobre apnea obstructiva del sueño
18. [Translated article] International consensus document on obstructive sleep apnea
19. Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder
20. HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
21. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study
22. Cholinergic dysfunction in isolated rapid eye movement sleep behaviour disorder links to impending phenoconversion.
23. Cortical cholinergic dysfunction correlates with microglial activation in the substantia innominata in REM sleep behavior disorder
24. Significance of hyposmia in isolated REM sleep behavior disorder
25. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy.
26. Prodromal Parkinson disease in patients with idiopathic hyposmia
27. Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder
28. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study
29. Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease.
30. Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder
31. Prior exposure to concussions in patients with isolated REM sleep behavior disorder
32. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients
33. Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder
34. Is REM Sleep Behavior Disorder Changing? Secular Changes Versus Referral Patterns
35. Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
36. Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder.
37. Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder
38. Sleep in Gerstmann-Straüssler-Scheinker disease
39. Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
40. Misfolded α-Synuclein Assessment in Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder
41. HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease
42. Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease
43. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study
44. Chapter 14 - Motor symptoms in nonparaneoplastic CNS disorders associated with neural antibodies
45. Periodic Limb Movements During Sleep Mimicking REM Sleep Behavior Disorder: A New Form of Periodic Limb Movement Disorder
46. MAPT association with REM sleep behavior disorder
47. Low Specificity of Rapid Eye Movement Sleep Behavior Disorder Questionnaires: Need for Better Screening Methods.
48. Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
49. The Sleep Disorder in Anti-lgLON5 Disease
50. Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.